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Abstract
Interstitial cystitis/painful bladder syndrome is a major source of chronic pelvic
pain and disability affecting women of all ages, predominantly age 18 years and over.
Estimates of prevalence among US women range from 2.7% to 6.5% translating to 3.4
and 7.9 million women who have symptoms consistent with this debilitating condition
(Kerr, 2009). The bladder epithelium has been the focus for diagnosing and treating
symptoms of IC, however taking focus away from the bladder has opened the door for
clinicians to explore pelvic floor dysfunction indicating that pelvic floor therapies should
be a first line treatment for those women with IC/PBS (Peters & Carrico, 2006).
In this evidence based practice change project, the problem of IC/PBS has been
identified in a Urology/Gynecology practice in Northeastern Pennsylvania. Based on the
clinical problem, a thorough literature review emphasized the solution of pelvic floor
therapy as part of usual care to improve symptoms associated with IC/PBS. The evidence
based change project was based on the Rosswurm and Larrabee Model. Several meetings
were held with the office staff along with a local pelvic floor therapist to discuss details
of the EBP change project including the effects this may have on the practice and patient
centered care. The project was submitted to Misericordia University’s Internal Review
Board and IRB approval was obtained for this project to move forward.
Women who were 18 years or older who presented with symptoms of IC/PBS
receive a complete history and physical examination, voiding diary, post void residual,
full gynecological examination, urinalysis with culture, urine cytology if the patient had a
smoking history, and a pain evaluation was performed. These women were invited to
	
  
	
  

	
  
	
  

participate in the EBP change project. The O’Leary-Sant questionnaire which measures
urinary and pain symptoms as well as how problematic these symptoms were to quality
of life was performed for a baseline measure. The patient was then educated on usual care
in conjunction with pelvic floor therapy. The EBP change project was explained and
informed consent was reviewed. If the patient chose to be a part of the project, 8 to 12
sessions of pelvic floor therapy was provided by a trained physical therapist at a local
rehabilitation center. The patient then returned to the practice setting at 4 weeks and 8
weeks for follow-up evaluation at which time the O’Leary-Sant questionnaire was readministered.
The pre-test and post-test data was compiled to determine if women showed
improvement of symptom and problem indices related to IC/PBS. All of the women in
the project reported symptom and quality of life improvement.
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Chapter One: Overview of the Problem of Interest
According to the Interstitial Cystitis Association (2014), Interstitial cystitis (IC) is
a chronic, severely devastating urinary bladder disease characterized by symptoms of
pelvic pain, excessive urinary frequency, urgency and nocturia that affects between four
and 12 million people in the United States. Although children and adult men can get IC,
women account for 90 percent of the cases with the average age of onset of 40 years.
Twenty-five percent of these women are under the age of 30 years. The National Institute
of Diabetes and Digestive and Kidney Diseases (NIDDK) 2011, developed inclusion and
exclusion criteria for patients who were being evaluated for Interstitial Cystitis/Painful
Bladder Syndrome (IC/PBS) with inclusion criteria consisting of bladder pain, urinary
urgency and frequency, bladder capacity of less than 350 mL and cystoscopic evidence of
a Hunner’s ulcer. However this criteria would have misdiagnosed more than 60% of
patients diagnosed by researchers as definitely having or likely to have IC/PBS (Metts,
2001). The NIDDK (2011), has expanded its definition to include not only those with
pinpoint hemorrhages or bladder ulcers identified on cystoscopy and hydrodistention,
(which is a procedure performed under general anesthesia that stretches the bladder by
filling it with water), but to also include those with only symptoms of urinary urgency,
frequency, and pelvic pain who had identifiable causes ruled out, such as urinary tract
infections, bladder cancer, and endometriosis. Researchers have recently started to use
the term “painful bladder syndrome” (PBS) to describe such cases as well (Khoudary,
Talbott, Bromberger, Chang, Sonder & Davis, 2009).
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Although IC/PBS accounts for a small percent of health care visits, it’s economic
burden is significant. According to Payne, Joyce, Wise & Clemens, (2007) the rate of
hospital outpatient visits between 1992 and 2001 for IC increased two-fold with
physician office visits increasing three-fold. The annual rate was 102 office visits per
100,000 of the population with the diagnosis of IC being associated with a two-fold
increase in direct medical costs. Between 1994 and 2000 the annual national expenditures
for IC were stable at $37 million however the annual costs for painful bladder syndrome
increased from $481 million to $750 million.
IC/PBS symptoms have shown to result in poor quality of life involving sleep
dysfunction, depression, anxiety, and stress, which also affect family relationships and
responsibilities. The need for innovative ways to treat IC/PBS has become a public health
goal to help decrease health issues and improve quality of life (Bosch & Bosch, 2014).
Because of misdiagnosis, the accurate burden of IC/PBS on the health care system in the
United States is undoubtedly underestimated in relation to administrative data that rely on
physician coding to identify this disorder (Payne, Joyce, Wise & Clemens, 2007).
The purpose of this evidence-based practice change project is to evaluate the
impact of pelvic floor therapy as usual care on improvement and reduction of IC/PBS
symptoms. According to guidelines offered by the American Urological Association
(2013), usual care of IC/PBS includes first-line treatment, which involves patient
education, self-care practices and behavior modification such as diet modification to
include the elimination of caffeine, alcohol, acidic or spicy foods, bladder retraining, selfhypnosis, gentle, non-jarring exercise/stretching, wearing comfortable, non-binding
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clothing, shoes, hosiery and underwear as well as stress management and coping
techniques to include relaxation and visual therapy. Second line treatments include
manual maneuvers that resolve pelvic, abdominal and/or hip muscular trigger points as
well as Kegel exercises and multimodal pain management approaches to include
pharmacological interventions such as oral and intravesical therapy. Further treatment
guidelines include surgical options, which will not be addressed as usual care in this
practice change project.
Unfortunately, even in conjunction these therapies are often suboptimal in
alleviating IC symptoms perhaps in part because many of the patients also suffer from
pelvic floor spasms, which cause pelvic pain. Women with IC and pelvic pain were
referred to the Beaumont Women’s Initiative for Pelvic Pain and Sexual Health program
where a comprehensive patient history and pelvic examination were completed by a
certified women’s health nurse practitioner. Seventy women were evaluated with the
mean age of 45 and standard deviation of 12 years. The majority (87%) of the sample had
levator pain. The levator ani muscle or pelvic floor muscle is a broad, thin muscle
situated on the side of the pelvis. The average levator pain score was 4.48 out of 10. If
pelvic floor dysfunction is diagnosed in IC patients, then current literature supports that
appropriate manual physical therapy techniques by properly trained clinicians should be
offered to patients who present with this disease (Peters, Carrico, Kalinowski, Ibrahim, &
Diokno, 2007).
Background
An 1836 textbook by a Philadelphia surgeon Joseph Parrish documented a
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syndrome of chronic frequency, urgency, dysuria and pelvic pain, which he coined “tic
doloureux of the bladder”. This diagnosis was used to describe painful, idiopathic nerve
disorders. Parrish accredited this term to his mentor, Dr. Phillip Syng Physick who
applied it to patients with severe lower urinary tract symptoms with the most common
etiology being bladder stones. By 1808, Physick had developed the concept of bladder
inflammation, or bladder ulcer in the absence of bladder stones (Parsons & Parsons,
2004).
According to Peters and Carrico, (2006), more than ninety years ago, interstitial
cystitis was described as a distinct ulcer clearly seen on cystoscopy. Therefore the
bladder epithelium had been the single focus of the pathogenesis of IC. Another
assumption was that the bladder stores toxic urine, and for the bladder to function as a
storage organ, it must protect itself from irritants and toxins in the urine. If this protective
layer is compromised, the urine will act as an irritant and, penetrate into the detrusor
muscle leading to proliferation of mast cells, which causes nerve upregulation, and
ultimately causes urinary urgency, frequency and pain. Therefore treatment had been
directed at treating the bladder epithelium. However, only 10% to 20% of patients with
symptoms of IC have ulcers within their bladder.
Therefore the clinician must first consider the patient to have chronic pelvic pain
thus using the term IC or PBS for only those patients whose symptoms are identifiably of
the bladder origin. Taking the focus away from the bladder has opened the door for
clinicians to explore other causes and treatment for this complex syndrome. Myofascial
pain which affects the muscles and the sheath of the tissue and hypertonic pelvic floor
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dysfunction are present in as many as 85% of patient with IC. A noxious stimulus may
trigger the release of nerve growth factor in the periphery causing the mast cells in the
bladder to release pro-inflammatory substances therefore causing neurogenic
inflammation of the bladder wall. This hypertonic state may result in decreased muscle
function, increasing myofascial pain. The pelvic floor muscles then become a source of
pain even when the bladder is treated (Peters & Carrico, 2006)
Significance
The RAND Interstitial Cystitis Epidemiology (RICE) study was an observational
study from 2006 to 2009 that sought to develop a case definition for IC/PBS with known
sensitivity and specificity and to estimate the prevalence of the disease, which at that time
had never been done using a large-population model (Konkle et al., 2012). This study
was lead by researchers from RAND Corporation measuring the prevalence of a
constellation of symptoms that are consistent with those conditions in the population of
U.S. women. The researchers conducted telephone interviews with a sample of nearly
600 women diagnosed by clinicians with IC/PBS and or other similar comorbidities to
pinpoint questions that had identified women diagnosed with IC/PBS and differentiated
them from women diagnosed with other conditions. A second phase of the study used a
two-stage population screening tactic. First, a collection of telephone interviews was
generated from nearly 100,000 households to screen for the presence of women with
bladder symptoms. A second step of screening was conducted to identify women who
met IC/PBS criteria. This study found that approximately 2.7% to 6.5% of American
women age 18 years and over met symptom criteria for IC/PBS. When extra-populated to
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the general population, these numbers translate to between 3.4 and 7.9 million women
who have symptoms consistent with this debilitating condition (Kerr, 2009).
The key to significant symptom reduction and improved quality of life includes
early diagnosis and treatment. Yet this disease is often under diagnosed or misdiagnosed,
both because of the many comorbidities found in patients with this disease and because
symptoms overlap with those of other common conditions. These patients are turning to
family practitioners first for help, yet recent surveys of clinician practices have found
significant knowledge gaps with regards to IC/PBS among primary care practices
(Theoharides & Whitmore, 2011). Although interstitial cystitis has been recognized since
1836, its etiology and pathogenesis are still unclear. Therefore it is not surprising that
IC/PBS patients suffer on average five to seven years and often visit as many as eight
clinicians before the correct diagnosis is made.
No infectious organism has been recognized as a cause for IC/PBS and symptoms
associated with this disorder are similar to those of a number of conditions, including
urinary tract infections, overactive bladder, allergies, chronic fatigue syndrome,
endometriosis, fibromyalgia, and vulvodynia to mention a few. Therefore IC/PBS is
largely a diagnosis of exclusion. When a patient presents with suprapubic discomfort or
pressure related to bladder filling and increased urinary frequency lasting for several
months, these other related conditions must be ruled out. Basic assessment should include
a medical history, voiding diary, post void residual, full gynecological examination,
urinalysis with culture, urine cytology if the patient has a smoking history, symptom
questionnaire and pain evaluation (Theoharides & Whitmore, 2011).
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Question Guiding the Inquiry
Evidence based practice is a problem-solving approach to the delivery of health
care that links the best evidence from studies and patient care data with clinician
expertise and patient preferences and values. When delivered in a framework of caring
and in a supportive organizational culture, the highest quality of care and best patient
outcomes can be achieved (Overholt, Melnyk, Stillwell, & Williamson, 2010).
The question guiding the inquiry for this evidence-based change practice is: “In
women 18 years and older with interstitial cystitis/painful bladder syndrome, does pelvic
floor therapy as part of usual care improve symptoms as indicated by a reduction in the
patients O’Leary-Sant Interstitial Cystitis Symptom and Problem Index (ICSI) score over
an 8 week period?”
The patient population (P) represents the population or topic of interest. This
evidence-based project has focused on women aged 18 years and older with interstitial
cystitis/painful bladder syndrome. The population of interest was chosen because the
RAND interstitial cystitis epidemiology study aimed at estimating the national prevalence
of interstitial cystitis/painful bladder syndrome has indicated that between 3.3 and 7.9
million American women older than 18 years of age as having bladder symptoms
associated with IC/PBS (Konkle, et al., 2012).
The intervention, (I), included pelvic floor therapy as part of usual care to
improve IC/PBS symptom and problem index. According to Bosch and Bosch (2014), the
management of IC/PBS includes first-line treatment, which includes patient education,
self-care practices, behavior modification, stress management and coping techniques.
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Guidelines offered by the American Urological Association (AUA, 2013) discuss secondline treatments to include manual maneuvers that resolve pelvic, abdominal and/or hip
muscular trigger points, lengthen muscle contractures, and release painful scars and other
connective tissue restrictions, as well as Kegel exercises and multimodal pain
management approaches to include oral and intravesical pharmacological interventions.
These guidelines provided by the AUA included an additional systematic review
conducted July 2013 to maintain guideline currency with newly published relevant
literature. A high evidence strength rating demonstrates appropriate manual physical
therapy techniques available by appropriately trained clinicians should be offered to
patients who present with pelvic floor tenderness.
A physical therapist who is experienced in treating people with pelvic pain or
women’s health problems, having completed a residency or fellowship in women’s health
physical therapy and having the advanced knowledge, experience, and skills that apply to
this condition was recommended. The initial visit consisted of an assessment that may
include looking for both external muscle problems and an internal exam if tolerated. If
the internal exam could not be tolerated it would be postponed until it can. The physical
therapist would then evaluate the patient while standing, walking and sitting in order to
judge whether their joints or posture may affect the pelvic floor as muscle problems in
the lower back, hips, buttock or thighs can stress the pelvic floor muscles contributing to
pain.
The foundation of physical therapy for pelvic pain is hands on treatment, which
should include both external and internal techniques, however therapists will not use
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internal techniques until the patient is comfortable with them. External techniques may
include; skin rolling, deep tissue massage (myofascial release), trigger-point therapy to
release tight spots, nerve release and joint mobilization. To treat the pelvic floor
internally, the therapist may insert a finger or an appropriate instrument in the vagina or
rectum to massage the muscles and connective tissue to release trigger points. A common
trigger point release technique includes pressure on the spot until it relaxes. Internal
massage is also used to release nerves. Pelvic floor therapy is normally covered by the
patients insurance (ICA, 2013).
The comparison group or (C) included multimodal therapy and consist of patient
education in regards to dietary modification to include elimination of bladder irritants,
bowel function, sexual activity, stress management, self-care and emotional support
which is deemed usual care (Bosch & Bosch, 2014).
According to Peters and Carrico (2006), despite many studies evaluating the
multiple therapies directed at treating the epithelium for IC/PBS, few have proven
effective when studied in a rigorous approach using a placebo-controlled trial. As many
patients have not found symptom relief with these therapies alone, pelvic floor
dysfunction is frequently believed to be present in these patients.
The intended outcome (O) for this capstone project was to improve symptom
management. Barkin (2002) reports the importance of quantifying the patient’s symptoms
such as pain and voiding complaints as well as how bothersome they are. He discussed
the O’Leary-Sant Interstitial Cystitis Symptom and Problem Index, which was developed
to do just that. Results of this self-administered questionnaire provide a way to grade the
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patient with respect to urinary and pain symptoms, and how problematic the symptoms
are for the patient.
A study by Bogart, Suttorp, Elliott, Clemens, and Berry (2012) evaluated a
quality of life scale adapted from the RICE BSE-6 scale which was used to assess the
impact of IC/PBS on life and sexuality, and was modified based on expert opinion and
focus group work to specify items valuable to IC/PBS to validate scales of symptom
severity, mental and physical health related to quality of life, such as depression, coping,
and perceived control. The RICE BSI-6 showed excellent internal consistency and strong
validity. It will also be used to examine effects of psychosocial and treatment
interventions on Quality of life among women with IC/PBS. These outcomes would be
measured at the initial visit, 4 weeks and 8 weeks.
In order to properly apply the intervention, an appropriate time (T) had to be
established. This evidence-based practice change project occurred over an 8-week period.
Fitzgerald, et al. (2012) have noted improvement of IC/PBS symptoms after patients
received up to ten, 60-minute treatment sessions over a 12 week period of time however
due to time constraints, evaluation for this EBP change project would evaluate symptom
and problem management over an 8 week time period.
System and Population Impact
IC/PBS symptoms are associated with pain; causing poor quality of life with sleep
dysfunction, sexual dysfunction, depression, anxiety, and stress. Employment is
problematic or impossible in 84% of those affected and family relationships and
responsibilities are negatively affected in 70% of these patients. The cost of medical care
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for an IC/PBS patient is more than $11,000 per year with narcotics being the most
commonly prescribed class of medication. IC/PBS is a chronic condition that can be
controlled, but not cured. Aside from causing physical suffering, chronic diseases place
an immense economic burden on our society. Psychological factors include chronic pain,
misdiagnosis, multiple trips to the bathroom causing lack of sleep, multiple doctor’s
visits, various diets and unnecessary antibiotics (Bosch & Bosch, 2014).
The RAND Interstitial Cystitis Epidemiology Study (RICE) group administered a
questionnaire to 599 women with IC/PBS, overactive bladder, endometriosis or
vulvodynia. The sensitivity and specificity of each definition was calculated using
physician assigned diagnosis as the standard reference. No single epidemiological
definition had high sensitivity and high specificity. The findings indicated that 6.5% of
American women met the high sensitivity IC/PBS criteria and 2.7% met high specificity
IC/PBS criteria, indicating that painful bladder symptoms are common in the US. This
study compared basic clinical and demographic characteristics of all women meeting the
criteria with those of previously described IC/PBS in a clinical cohort. Some differences
were observed among these clinical and community groups, however overall IC/PBS
samples were strikingly similar with the most demographic difference observed being the
lower rate of health insurance. These findings strengthen the body of evidence that
suggests that this disorder is significantly burdensome, and likely under-diagnosed and
undertreated in the United States.
IC/PBS must be viewed as a chronic disease requiring a long-term health care
plan. Validation of this disease is important to patients, as many have been living with
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IC/PBS symptoms for years. Patients need to be reassured that they are not the only
persons with these symptoms and that they are experiencing a well-described syndrome
that is not life threatening and is treatable. According to Bosch and Bosch (2014), both
medical and social treatment options should be utilized in the care of this disease, as there
are social and environmental factors involved.
Purpose, Aims/Objectives 	
  
Interstitial cystitis/painful bladder syndrome is a visceral pain syndrome with a
significant impact on quality of life. The main aims of this project were as follows: (1) to
determine the presence of pelvic floor dysfunction in women within a women’s health
practice diagnosed with interstitial cystitis, painful bladder syndrome; (2) to evaluate the
impact of pelvic floor therapy as part of usual care in adult women age 18 years and older
with interstitial cystitis/painful bladder syndrome; (3) to promote symptom reduction
with pelvic floor therapy over an 8 week period. If pelvic floor dysfunction is found in
IC/PBS patients, then therapy targeting the pelvic floor musculature should be considered
a part of a first line approach to treating this disorder.
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Chapter Two: Review of Evidence/Literature
	
  

Methodology
An extensive search of current literature was first conducted to answer the PICOT question; In women 18 years and older with interstitial cystitis/painful bladder
syndrome, does pelvic floor therapy as part of usual care improve symptoms indicated by
reduction in the patients O’Leary-Sant Interstitial Cystitis Symptom and Problem Index
(ICSI) score over an 8 week period.
Initially a search was conducted through databases such as Cochrane database of
systemic reviews, National Guideline Clearing House, Sigma Theta Tau, Evidence Based
Nursing, and Health Information Resources. Unfortunately, a search of these databases
yielded very little results. One guideline published by the American Urological
Association on the diagnosis and treatment of IC/PBS was found. The search was then
broadened to include a thorough search of CINAHL Complete, MEDLINE, and Health
Source: Nursing/Academic Edition. Articles included were published after the year 2004
to ensure recent literature as well as sufficient quality studies.
Key terms used in the search included: title, keywords and abstracts of interstitial
cystitis, painful bladder syndrome, pelvic floor tenderness, pelvic floor dysfunction,
pelvic floor therapy, management, oral management, oral therapy, behavior management,
assessment, diagnosis, treatment, complementary therapies and evaluation of symptoms.
“Interstitial Cystitis” and “Painful bladder syndrome” yielded 498

	
  

•

Years 2004 -2014 yielded 472

•

Academic Journals yielded 414
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•

Females yielded 226

•

Adults 19+ years yielded 122

“Interstitial Cystitis” and “Pelvic Floor Tenderness” yielded 2 including academic
journals.
“Interstitial Cystitis” and “Pelvic Floor Dysfunction” yielded 13; included years 20042014
•

Academic Journals yielded 14

•

Females / NA

•

Adults 19+years yielded 5

“Interstitial Cystitis” and “Pelvic Floor Therapy” yielded 28; included years 2004-2014,
all Academic Journals
•

Females 28

•

Adults 19+ years yielded 10

“Interstitial Cystitis” and “Management” yielded 225; included years 2004-2014
•

Academic Journals yielded 208

•

Females yielded103

•

Adults 19+years yielded 37

“Interstitial Cystitis” and “Oral Management” yielded no results
“Interstitial Cystitis” and “Oral Therapy” yielded 5; included years 2004 -2014
•

Academic Journals yielded 5

•

Females /Adults 19+ years /NA

“Interstitial Cystitis” and “Behavior Management” yielded no results
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“Interstitial Cystitis” and “Assessment” yielded 162; included years 2004-2014
•

Academic Journals yielded 155

•

Females yielded 107

•

Adults 19+years yielded 83

“Interstitial Cystitis” and “Diagnosis yielded 686; included years 2004-2014
•

Academic Journals yielded 628

•

Females yielded 429

•

Adults 19+years yielded 256

“Interstitial Cystitis” and “Complementary Therapies” yielded no results
“Interstitial Cystitis” and “Evaluation of symptoms” yielded 2; included years 2004-2014
and academic journals
Articles were included if they were published after 2004 to ensure recent literature
and sufficient quality studies. All articles included those published in English; however,
articles from countries other than the United States were included as long as they were
available in English. Articles were limited to the care of adults. Articles that pertained to
interstitial cystitis in men were excluded because the PICO-T question specifically
addressed the management of IC/PBS in women. However, studies that included both
men and women could not be excluded, due to findings being pertinent to the
management of IC/PBS in women. The search was not limited to nursing literature as
other disciplines such as physical therapy have contributed extensive research on the
topic of interstitial cystitis/painful bladder syndrome and pelvic floor therapy.
An advanced search aimed at selecting articles with a high grade of evidence with
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special limitations to include Randomized Controlled Trials, Systematic Reviews,
Practice Guidelines, Meta Analysis and Journal Articles. A comprehensive review had
determined that the AUA Guidelines are the most comprehensive guideline currently
available. The search for unpublished studies included: Google scholar and dissertation
abstracts.
Findings
The priority in selecting articles was to choose articles with a high grade of
evidence whose content most specifically addressed the PICO-T question. When
choosing which articles to evaluate, the hierarchy of evidence that was used to select
articles for inclusion, and to evaluate those articles, was presented by Fineout-Overholt,
Melnyk, Stillwell, and Williamson (2010). The levels of hierarchy are as follows from the
lowest level of evidence to the highest: 1 expert opinion, 1 cohort study with high risk of
bias, 2 randomized control trials (RCT’s) and 2 systematic reviews.
The American Urological Association (AUA) Guidelines for the Diagnoses of and
Treatment of Interstitial Cystitis/Painful Bladder Syndrome by Hanno et al. (2011), was
analyzed as part of the review by using the Appraisal of Guidelines Research and
Evaluation (AGREE) instrument. The AGREE instrument was rated by this author on its
performance in the following six categories: scope and purpose 75%, stakeholder
involvement 70%, rigor 70%, clarity 88%, applicability 30%, and editorial independence
75%. The AUA guideline was developed by a committee of urologists, nurses, and other
clinicians with specific expertise on IC/PBS.
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The Committee conducted a systematic review of MEDLINE, of publications in
English published between 1983-2009. Meta-analysis of randomized controlled trials and
systematic reviews were used to identify peer-reviewed publications relevant to the
diagnosis and treatment of IC/PBS. The review yielded an evidence base of 86 treatment
articles after application of inclusion/exclusion criteria. Inclusion criteria consisted of the
terms, “interstitial cystitis”, “painful bladder syndrome”, “bladder pain syndrome”, and
“pelvic pain” as key words capturing the various diagnostic procedures and treatments
known to be used for such syndromes. Preclinical studies (animal models), pediatric
studies, commentary, and editorials were excluded. An additional systematic review was
conducted in July 2013 to maintain guideline current with newly published relevant
literature. This review identified an additional 31 articles relevant to treatment. When
sufficient evidence was present the body of evidence for a particular treatment was
assigned a strength rating of A (high), B (moderate), or C (low). Additional treatment
information was provided as clinical principles and expert opinion when insufficient
evidence existed.
Treatments that may be offered are divided into first line treatments to include
general relaxation and stress management, pain management, education and behavior
modification. Second line treatments include pelvic floor therapy, multimodal pain
management, oral medications and intravesical treatment. Third line treatment
recommends cystoscopy with hydrodistention, which is a procedure performed under
general anesthesia that stretches the bladder by filling it with water. If Hunner’s lesions
are present then fulguration, which is electrocautery of the lesions, should be performed.
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Fourth line treatment includes injections of abotulinum toxin A into the detrusor muscle,
fifth line treatment oral cyclosporine and sixth line treatment major surgery to include
substitution cystoplasty which is excision of the symptomatic bladder with reconstruction
to produce a low pressure reservoir using a segment of remodeled intestine anastomosed
to the bladder remnant or urinary diversion with or without cystectomy which includes
rerouting urine flow from its original pathway.
The chief weaknesses of this guideline are essentially due to the lack of available
scientific research to support the guideline and disease process of IC/PBS. The medical
community wrote the guideline for healthcare providers and patients based on subjective
evidence from experts caring for patients with IC/PBS. The authors did not address the
cost of treatments or consider any contributions from patients with IC/PBS. There is little
evidence supporting a single treatment of choice for the majority of IC/PBS patients.
Limitations include poorly defined patient groups, small sample sizes, lack of placebo
controls for many studies likely overestimating efficacy, short follow up durations and
the use of a variety outcome measures.
Anderson and Perry (2006) completed a MEDLINE, EMBASE and AdisBase
search to examine Pentosan Polysulfate (Elmiron) use in the relief of bladder pain or
discomfort in IC vs. placebo and other therapies such as hydroxyzine and cyclosporine’s.
A randomized, double blind, multicenter, dose ranging, 32-week study (n=380),
compared the efficacy of 300, 600, and 900 mg per day dosages of oral Elmiron in IC
patients with no dose-response relationship seen. According to O’Leary-Sant Interstitial
Cystitis Symptom Index scores, there was a significant (p < 0.001) improvement from
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baseline at the 300-mg/day dosage (n = 128). In addition, improvement in the patient’s
overall rating of symptom index of > 50% increased from 21.1 % after 4 weeks of
treatment to 49.6% after 32 weeks of therapy.
Elmiron was significantly more effective than placebo in relieving symptoms of
patients with moderate or severe IC in two placebo-controlled trials: Mullholland et al.
(1990), (n = 110), and Parsons et al. (1993), (n=148). In both studies, significantly larger
proportions of patients with IC showed improvement of their overall condition when
treated with Elmiron versus placebo. Assessment of pain and urgency were similar across
both studies with a larger proportion of patients experiencing a substantial relief in pain
and urgency when treated with Elmiron compared to placebo. The mean reduction from
baseline in the pain score was not significantly different between Elmiron or placebo
recipients in the trial reported by Mullholand et al. (1990); although, the reduction in the
mean pain score for patients receiving Emiron was significantly (p = 0.05) different from
zero or no change.
In a six month Finnish urology clinic study comparing the efficacy of Elmiron
with cyclosporine in patients with IC, the proportion of patients reaching the anticipated
primary end point of 50% reduction in frequency in 24 hours in Elmiron versus
cyclosporine recipients was 0% versus 34% (p <0001). Cyclosporine may show to be
beneficial for patients who have not benefited from other IC therapies; however the
tolerability profile suggests that patients treated with this drug need to be regularly
monitored for blood pressure and serum creatinine. Over half of the patients in this study
had at least three previous unsuccessful treatments and the mean patient age, at 58 years,
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was higher than in most of the studies discussed.
The long-term efficacy of oral Elmiron 100 mg three times daily for up to 35
months has been evaluated in a large, multicenter, physician’s trial with (n = 2809).
Improvement in symptoms of IC were reported and patient evaluation demonstrated that
the proportion of patients completing at least 3 months of Elmiron therapy (n=1416) with
at least moderate improvement in their overall assessment of IC symptoms. The majority
of patients in this trial had moderate or sever symptoms with the average patient age
being 46.9 years. Over half of the patients had been treated with at least one course of
intravesical dimethyl sulfoxide.
Primary efficacy outcomes included patient rated evaluation questionnaires
targeting overall improvement of conditions; daily micturition frequency and patient
reported 7-point global response assessment (GRA). Secondary efficacy outcomes
included evaluation of overall improvement by pain and urgency scale rating, changes in
O’Leary-Sant symptom problem indexes and a six point scale GRA. Weaknesses include
possible bias due to withdrawals, study design limitation and limited statistical power due
to low rates of recruitment. Although this study had limitations as noted above, it is still
considered to be valid as current literature supports Elmiron use as an important option in
treatment of IC (Anderson & Perry, 2006).
Khoudary et al. (2008) is a cross-sectional analysis of 41 subjects age 20 -71
years with moderate to severe IC enrolled in an 18 week, randomized, double-blind,
placebo controlled clinical trial to assess the efficacy and safety of a combination of
intravesical and oral Elmiron compared to placebo as a new therapeutic selection for IC

	
  

21	
  
	
  

with the objective of determining possible factors that may increase the severity of
symptoms and decrease quality of life in women diagnosed with IC; how symptom
severity affects quality of life adjusting for these factors; and to investigate which
symptoms would be most likely to impair IC patients’ physical and mental quality of life.
Females 18 years and older who recently met the NIDDK criteria for IC and were
previously untreated with Elmiron were recruited from IC patients of Citrus Valley
Medical Research Inc. Women were required to have a negative urine culture, a score of
at least four on a nine-point pain scale and five on the O’Leary-Sant Interstitial Cystitis
Symptom Index at baseline. All subjects signed an informed consent, and the study
design was approved by the IRB of Foothill Presbyterian Hospital in Glendora CA and
the IRB of the University of Pittsburgh.
The conclusion of the parametric technique is based on the large sample
properties. With a sample size of 41, the properties may not be applied. Therefore the
authors used a non-parametric approach to assess the study aims. Continuous variables
were presented as median, 25th and 75th percentiles while categorical variables were
presented as percentages. Spearmen correlations, Mann-Whitney U-tests, and KruskalWallis tests were used to assess univariate relations. All statistical tests were two sided
and used a significance level of 5% and all analyses were conducted using STATA
version 10.0.
The results demonstrate that patients with IC reported a significantly poorer
quality of life than controls across all SF-36 domains (p<0.01). Weaknesses includes a
cross sectional design which limits the ability to determine the direction of causality
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between symptom severity and quality of life. A small sample size and strict application
of NIDDK criteria resulted in exclusion of mild cases. Patients with IC reported
significantly poorer quality of life than controls across all SF 36 domains. Therefore it
may be postulated that managing pain and nocturia in particular may improve the patients
overall physical and mental quality of life.
FitzGerald, et al. (2012) present a randomized, single-blind, randomized clinical
trial comparing pelvic floor Myofascial Physical Therapy (MPT) vs. Global Therapeutic
Massage (GTM). This study was performed at 11 clinical centers located in North
America. Recruitment consisted of women with IC/PBS who demonstrated pelvic floor
tenderness on physical examination and had a limitation of no more than three years of
symptom duration. Primary outcome was the proportion of responders defined as
moderately improved or markedly improved in overall symptoms compared to baseline
on a 7-point Global Response Assessment scale. Secondary outcomes included ratings of
pain, urgency and frequency on the O’Leary-Sant IC Symptom index. Response rates
were compared between treatment arms using the exact conditional version of the
Mantel-Haenszel test to control for clustering by clinical center. For secondary efficacy
outcomes, cross-sectional descriptive statistics and changes from baseline were
calculated.
Recruitment was at a rate slower than expected with limited funding therefore the
study was closed prior to reaching the recruitment of 88 patients. A total of 81 patients
were recruited between July 2008 and May 2009. The majority were white women with a
median age of 43 years. Ages ranged from 18-77 years. There were no statistically
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significant differences between the two treatment groups in demographic characteristics.
This study was still adequately powered to identify significant differences in the primary
outcome of the study. Overall 59% in the MPT group and 26% in the GTM group
reported moderate or marked improvement (p=0.0012) with 43% in the GTM group
reporting no improvement. This study supports the concept of pelvic floor MPT for the
treatment of IC/PBS as a significantly higher proportion of women with IC/PBS
responded to treatment with MPT. The population includes female aged 18-77 years to
support PICO-T criteria.
Berry et al. (2010), used an adaptation of risk assessment methodology (RAM),
which is a methodology used to determine the appropriateness of various symptom
indicators to diagnose IC/PBS compared with indicators of conditions with overlapping
symptoms, such as overactive bladder, endometriosis and vulvodynia. Nominations were
solicited from relevant medical societies, including the American Urological Association,
American College of Obstetrics and Gynecology, and American Urogynecology Society
as well as recognized IC/PBS experts. Nine experts were chosen for the final
multidisciplinary panel, including five in urology, two in gynecology, one in nursing and
one in case definition methodology.
A comprehensive literature review of the best scientific evidence in regard to
IC/PBS and related conditions with overlapping symptoms using the PubMed database
and predefined search terms was performed. The final review involved a history of the
case definition of each disease and a description of the prevalence of patient reported
symptoms both within and across diseases.
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Forty-two urologists and gynecologists around the Unites States were contacted
with eight urologists and 16 gynecologists accepting participation. A total of 673
participants were recruited of whom 599 were interviews. The diagnosis was IC/PBS
only in 236, IC/PBS plus one of the other conditions in 101, overactive bladder in 124,
endometriosis in 58, vulvodynia in 44 and more than one non IC/PBS condition in 36.
These participants completed a comprehensive 90-minute computer assisted telephone
interview conducted by trained interviewers from the RAND Interstitial Cystitis
Epidemiology telephone survey center. Physician clinical diagnoses served as the
reference standard to define IC/PBS. A repeated approach to construct and test different
combinations of the RAND Interstitial Cystitis Epidemiology study items were used to
predict the IC/PBS diagnosis (sensitivity) and differentiate IC/PBS from other conditions
(specificity).
The findings conclude that no single definition is associated with high sensitivity
and specificity, which may be related to the true overlap of symptoms across these
conditions, or to the accuracy of measurement and clinical diagnoses of these conditions
demonstrating that more meaningful comparison across samples is required. Previous
measures used to identify patients with IC/PBS were developed to track the course of the
conditions. The RAND Interstitial Cystitis Epidemiology cohort (RICE) measures are
designed to identify women with IC/PBS and describe their symptoms. These measures
along with other means will be used in this evidence-based project for symptoms
evaluation.
Chung, Liu, Li and Lin (2014), performed a cross-sectional study to compare the
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difference in the utilization of healthcare services between patients with IC/PBS and
patients without using a population-based database in Taiwan. The study comprised of
350 patients with IC/PBS and 1,750 age-matched controls. Data on the sampled subjects
and their utilization of healthcare services were recovered from the Longitudinal Health
Insurance Database. This database contained complete medical claims and registration
files for 1,000,000 enrollees, who were randomly selected from all enrollees listed in the
2000 registry of beneficiaries under the National Health Insurance program.
This study first identifies 512 female patients who had received a first-time
diagnosis of IC/PBS during an ambulatory care visit between January 2006 and
December 2010. Due to stringent oversight of peer reviews for the prescription of
Cystistat, it is unlikely that misdiagnosed cases were included in the study group. In order
to increase the validity of the IC/PBS diagnoses, this study only included patients who
had received a prescription for Cystistat. Those patients <18 or >80 (n=11) years of age
were excluded leaving an overall number of 350 IC/PBS patient cases in the study group.
For controls, the data was also retrieved from the Longitudinal Health Insurance
Database. Female subjects between 18 and 79 years old were identified. Those who
already had prior history IC/PBS were excluded from the study. Then 1,750 were
randomly selected who matched to the study cases by age and index year through a
survey select program.
An SAS system for windows statistical analysis package was used to conduct the
statistical analyses. Descriptive statistical analysis, including frequency, percentage,
mean and standard deviations were performed on all outcome variables. Student’s t-tests
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were carried out to examine the relationships between outcome variables for patients with
IC/PBS and controls. Additionally, a multivariate-regression-analysis was used to model
the logarithm of mean costs as a liner function of a set of independent variables. The
difference was considered significant if a two-sided p value was <0.05. Of the 2,100
female study subjects, the mean age was 48.4 years old and approximately 50% were
older than 50. There was no significant difference in the geographic region between the
IC/PBS and controls (p=0.159).
This study found that female patients with IC/PBS had significantly more
outpatient visits for urological services than controls (mean value 2.5 vs. 0.2) during
follow up period. Of the 350 female patients with IC/PBS, 159 (45.4%) had ever used an
outpatient visit during follow-up period. This study reveals that female patient with
IC/PBS had significantly more outpatient visits (35.0 vs. 21.3) for non-urological reasons
as well as significantly higher total costs ($US 1149 vs. $US 900) than controls.
The principle strength of the study was in the use of a population-based dataset,
which mitigates the effect of selection bias inherent in voluntary registries. The database
used in the study also enabled the authors to trace the healthcare utilization of all study
subjects, which can reduce the potential recall bias present in a survey study. A noted
decreased cost and outpatient visits in quality of care along with population criteria are
both strengths noted in this study.
Limitations of Search and Review
In reviewing literature, limitations were encountered. Current research lacked
studies on the effectiveness of a multimodal approach to treatment of IC/PBS. A few
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studies showed benefits to stress reduction, behavior modification, improved coping
mechanisms, and diet modifications as first line treatment. The strongest evidence in the
form of RCT’s, meta-analysis, cohort studies and case studies addressing the
management of IC/PBS available focused on treatment with pharmacological measures.
The AUA clinical guideline did provide information in regards to manual physical
therapy as being second line treatment, however no studies were found to include manual
physical therapy as a first line treatment option.
Therefore a further search of PubMed to include the terms “Interstitial Cystitis”,
and “ Pelvic Floor Dysfunction” yielded 48
•

Publication dates of 10 years yielded 26

•

Humans 25

“Pelvic Floor Therapy”, and “Interstitial Cystitis” Publication dates of 10 years, humans
yielded 47.
Lukban, et al. (2001) performed a pilot study, which consisted of 16 female
patients with the mean age being 42.5 years who were diagnosed with IC, and high-tone
pelvic floor dysfunction, which was detected by trigger-point palpation on digital
examination by a Urologist. These patients were referred to physical therapy for
suspected sacroiliac dysfunction and were then issued an O’Leary-Sant Interstitial
Cystitis Symptom Questionnaire and Modified Oswestry Disability Scale prior to
evaluation. These questionnaires evaluate urinary frequency, nocturia, urgency,
suprapubic pain, and dyspareunia. Evaluation performed by a certified manual physical
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therapist identified sacroiliac dysfunction in all 16 cases. Manual therapy and an
extensive home exercise program for a mean of 8.72 (range, 2 to 15) visits. A
comparison of pre- and post treatment Modified Oswestry and O’Leary-Sant scores
revealed 94 % improvement in symptomatology with the greatest improvement seen in
the incidence of frequency and suprapubic pain, further suggesting support of this
evidence based practice change.
Conclusions
The evidence has shown that addressing the pelvic floor in patients demonstrating
IC/PBS symptoms has great importance. Findings revealed statistically significant
correlations between usual care and pelvic floor therapy related to both cost benefits and
quality of life to the patient. Utilizing the findings in practice and implementing
coordination of care between a practitioner and professionally trained physical therapist
would prove to be beneficial in the treatment of IC/PBS.
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Chapter Three: Framework of Theory
The Rosswurm and Larrabee Model was chosen for this evidence based practice
change. This model guides nurses and other healthcare professionals through a systematic
process, which tremendously increases the accessibility to research findings to prepare
the way for the paradigm shift from traditional intuition-driven practice to evidencebased practice (Gawlinski & Rutledge, 2008).
According to Gawlinski and Rutledge (2008), this model has six phases with aims
for integration of evidence based practice into a care delivery system which includes;
assessing the initial need for change in practice; linking the problem to standard
interventions and outcomes; synthesizing best evidence; design of practice change;
implementation and evaluation of change in practice and integrating and maintaining the
practice change.
Gawlinski and Rutledge (2008), describes each of the six phases. The first step
includes assessment of the need for change in practice by comparing internal data about a
specific current practice and comparing it with external data in standard databases.
Comparison of internal and external data may validate current practice or support the
need for a change in practice. For this evidence based change project current practice
includes dietary changes such as decreasing bladder irritants, timed voids, stress
management, education and behavior modification. Approximately 50 to 75% of patients
present with pelvic floor trigger points causing a somatovisceral response, which is pain
shooting in the perineum, bladder or pelvic organs validating support for a change in
practice.
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The second step involves linking the problem with interventions and outcomes.
Classification systems such as International Classification of Diseases (ICD) and
Diagnostic and Statistical Manual of Mental Disorders (DSM) help to define concepts of
a science, organize knowledge, facilitate communication among practitioners, provide
standards for determining effectiveness and cost of care, and identify needed resources.
According to the American Urological Association (2013), patients with IC/PBS were
identified in the electronic medical record by the presence of ICD-9 code 595.1
(interstitial cystitis), and the prevalence of the diagnosis was found to be 197 per 100,000
women and 41 per 100,000 men.
In the third step is where interventions and outcomes are refined by synthesizing
best research evidence and combining it with clinical judgment and contextual data to
determine whether the strength of the evidence supports a change in practice. Evidence
supports the issue of multimodal treatment approaches for IC to include pelvic floor
therapy performed by a trained physical therapist for pelvic floor muscle dysfunction
combined with usual care as noted above.
The fourth step involves the steps taken to design the change in practice. The
practice environment, resources and feedback for stakeholders are crucial considerations
when designing a change. Only activities addressed and population similar to those in the
evidence base are used to guide practitioners in identifying anticipated outcomes of the
practice change. For this EBP change project, individuals presenting to the
Urology/Gynecology practice setting with symptoms related to IC/PBS were evaluated
for participation in this project. A complete history and physical examination, voiding
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diary, post void residual, full gynecological examination, urinalysis with culture, urine
cytology if the patient has a smoking history, and pain evaluation was performed.
Individuals who meet specified inclusion criteria were invited to participate in this
project. The investigator then reviewed the informed consent (Appendix A) and
administered the O’Leary-Sant index questionnaire (Appendix B) which measures
urinary and pain symptoms, and how problematic these symptoms are for the patient. The
patient was then educated on self-care practices and behavior modification such as diet
modifications to include the elimination of caffeine, alcohol, acidic or spicy foods,
bladder retraining, gentle, non-jarring exercise/stretching, wearing comfortable, nonbinding clothing, shoes, hosiery and underwear as well as stress management and coping
techniques to include relaxation techniques. Pelvic floor therapy evaluation and treatment
of 8 sessions provided by a trained physical therapist at Allied Services was discussed
with these patients. If they so choose to proceed with pelvic floor therapy in conjunction
with usual care, pelvic floor therapy was ordered and scheduled.
Step five involves implementation and evaluation of the change in practice. This
stage requires close monitoring of the implementation process for success. Follow up
reinforcement of the practice change, which may include staff surveys and QI study for
data analysis. Interpretation of these results will determine whether the protocol was
implemented as intended and what affect it had on patient outcomes. The patient returned
to the Urology/Gynecology practice setting at 4 weeks and 8 weeks for evaluation by the
investigator at which time the O’Leary-Sant symptom and problem index questionnaire
was assessed.
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The sixth step includes integration and maintaining this change in practice. The
change agents need to consider the cultural climate of the organizations as they attempt
integration into practice innovations. Ongoing communication with stakeholders,
adherence to the details and continuing education ensures a smooth and speedy
integration of the change into the organization’s standards of care (Gawlinski &
Rutledge, 2008). At the conclusion of this EBP project, evaluation of its effectiveness in
improved symptoms indicated by reduction of the patients O’Leary-Sant Interstitial
Cystitis Syndrome index score was determined. Collaboration with ongoing stakeholders
will ensure a smooth integration of the change into the organization’s standards of care.
Relationship of Model to Project
Rosswurm and Larrabee’s model is an evidence based practice approach to
clinical care that incorporates the thorough use of current best evidence of well designed
studies, clinician’s expertise, and patient values and preferences. By using this problem
solving approach to clinical care that integrates the conscientious use of current best
evidence from well-designed studies, clinician’s expertise and patient values and
preferences, healthcare providers can provide care that leads to better clinical decisions
and patient outcomes.
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Chapter Four: Project Planning
	
  

Project Design
The management of IC/PBS is both frustrating and difficult as it is a diagnosis of
exclusion. Consequently, both patients and healthcare providers tend to be dissatisfied
with the quality of care. The American Urological Association (AUA, 2013) provides a
guideline for the diagnosis and treatment of IC/PBS. Recommendations for first line
treatment include patient education, self-care practices, behavior modification, and stress
management. These usual care therapies are often suboptimal in alleviating symptoms
related to IC/PBS. According to Peters and Carrico (2006), pelvic floor dysfunction
demonstrated by levator pain upon examination is present in as many as 85% of patient
with IC/PBS. This demonstrates the notion that pelvic floor therapy techniques performed
by properly trained clinicians should be offered as part of standard of care as a first line
approach.
The question guiding the inquiry for this evidence-based quality improvement
project is: In women 18 years and older with interstitial cystitis/painful bladder
syndrome, does pelvic floor therapy as part of usual care, improve symptoms indicated
by reduction in the patients O’Leary-Sant Interstitial Cystitis Symptom and Problem
Index (ICSI) score over an 8 week period.
The proposed evidence based practice change project was introduced in a
gynecology/urology office located in a suburban area in the northeastern United States.
The practice, located on the grounds of a large hospital, includes one doctor, and two
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nurse practitioners. Additionally, the office employed one registered nurse, one LPN, two
medical assistants, and 4 personnel in other clerical positions. The types of patients seen
in the practice include adolescents through elderly women who presented to the office for
well-woman examinations, acute gynecologic and urologic conditions, and chronic
gynecologic conditions.
Prior to implementing the EBP change project, there were several collaborative
meetings. The first meeting was with the collaborating physician and the other Nurse
Practitioner to discuss the evidence and the problem, as well as, to obtain permission to
perform the EBP change project. Both the physician and nurse practitioner were open to
the idea of this practice change. These practitioners agreed that IC/PBS was a common
problem among women that may go unaddressed at the annual visits. They were open to
efficient ways of improving patient care and satisfaction. It was agreed, that
implementation of this practice change should improve the overall diagnosis and
management of IC/PBS in women within the practice.
The next meeting was with the medical assistants and nurses who are directly
involved with initial intake of the patients problem. All questions were answered and any
concerns were addressed in regards to the details of the EBP change project and the staff
was satisfied.
The investigator also met with a local pelvic floor specialist to whom all referrals
would be directed. This meeting included discussion in relation to the treatment plan, the
use of the O’Leary-Sant Questionnaire, collaboration of care and follow up. There was
also a follow up meeting to brief the medical staff on the details of the EBP change
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project including the effects this may have on the practice, the project coordinator
discussed various aspects of the project so the staff remembered that the project would
begin in May 2015.
Individuals presenting to the Urology/Gynecology practice setting with symptoms
related to IC/PBS would receive a complete history and physical examination, voiding
diary, post void residual, full gynecological examination, urinalysis with culture, urine
cytology if the patient had a smoking history, and pain evaluation was performed.
Individuals who meet specified inclusion criteria were invited to participate in this
project. The investigator then reviewed the informed consent (Appendix A) and
administered the O’Leary-Sant index questionnaire (Appendix B) which measures
urinary and pain symptoms, and how problematic these symptoms are for the patient. The
patient was then educated on self-care practices and behavior modification such as diet
modifications to include the elimination of caffeine, alcohol, acidic or spicy foods,
bladder retraining, gentle, non-jarring exercise/stretching, wearing comfortable, nonbinding clothing, shoes, hosiery and underwear as well as stress management and coping
techniques to include relaxation techniques. Pelvic floor therapy evaluation and treatment
of 8 sessions provided by a trained physical therapist at Allied Services was discussed
with these patients. If they so choose to proceed with pelvic floor therapy in conjunction
with usual care, pelvic floor therapy was ordered and scheduled. The patient would come
into the Urology/Gynecology practice setting at 4 weeks and 8 weeks for follow-up
evaluation at which time the O’Leary-Sant symptom and problem index questionnaire
will be re-administered and added to the patients normal medical record. No experimental
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procedures were used in this quality improvement project.
Before this EBP change project could move forward the approval process
required submission to the Misericordia University’s Institutional Review Board (IRB).
The IRB has final approval of all academic projects. This approval was obtained on May
11, 2015 (Appendix C). There was no other formal approval process for projects required
by the clinical practice site, however verbal consent and approval from the office
manager and clinical practice preceptor was obtained prior to implementation.
Data Collection Tools
Data collection was maintained by the investigator within the Medent electronic
medical record, which is HIPAA and password protected. At the end of the 8 week
period, data was extracted from the patients’ normal medical files, reviewed
retrospectively, de-identified, and reported in aggregate form with no patient identifiers
used. In this EBP change project, data reviewed is a function of the patient’s normal
medical care.
Resources Needed
Plain white 8x11 inch paper and black ink were used to print the O’Leary-Sant
index questionnaire and educational information in regards to bladder irritants. Brochures
provided by the Interstitial Cystitis Association which had been obtained free of charge
were also be given to the patient. These brochures discuss standard of care, which
includes information regarding bladder irritants, stress management, and pelvic floor
therapy. Approximately, 30 copies of each of the participant consent, and bladder irritant
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sheet were produced for distribution to participants. Additional project documents were
printed as needed.
Budget Justification
No rewards or compensation was offered. Participants were allowed to withdraw
at any time with no penalty or impact on their medical care. No travel or lodging
expenses were acquired. This EBP change project was carried out in the investigators
clinical practice site, therefore examination and testing materials were implemented as
usual care practice therefore no expense were incurred. The investigator provided
materials needed to complete the EBP change project. These materials included paper
and ink, which were of minimal cost.
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Chapter Five: Implementation Procedures and Processes
IC/PBS has shown to result in poor quality of life involving sleep dysfunction,
depression, anxiety, and stress, affecting family relationships and responsibilities. The
need for innovative ways to treat IC/PBS has become a public health goal to help
decrease health issues and improve quality of life (Bosch & Bosch, 2014). The intent of
this evidence based change project was to evaluate the impact of pelvic floor therapy on
adult women with interstitial cystitis/painful bladder syndrome by symptom reduction.
This chapter discusses the project setting, participants, and implementation process to
include task list and time line.
Setting
The EBP change project was implemented in a corporation run
Urology/Gynecology (URO/GYN) practice in Scranton, Pennsylvania. The Interstitial
Cystitis Association, calculated estimates of people affected by IC/PBS by state based on
the US census bureau. According to these statistics, Pennsylvania likely has 163,793 497,931 men and women affected by IC/PBS (ICA, 2010). The practice site for the EBP
change project has 1 URO/Gynecologist, 2 Certified Registered Nurse Practitioners, and
8 support staff to include nursing, medical assistants and office personnel.
Participants
Participants that were included in this EBP change project were adult female
patients age 18 years or older, of all ethnicities, proficient in speaking, reading and
writing English, seen at the practice site requiring care for IC/PBS. Patients that were
excluded from this EBP change were males, females younger than age18, patients that
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were cognitively impaired, and those that had a hysterectomy or pelvic floor prolapse
repair within the past 6 months. Patients were recruited by an interdisciplinary team to
include the nurse practitioners, physician, nursing staff along with the office manager
who had access to the daily schedule and was educated on inclusion and exclusion
criteria for this project.
Implementation Process
According to the University’s requirements for implementing this evidence based
practice change project, the Institutional Review Board (IRB) approval process was
initiated. An EPB protocol was submitted and the EBP change project was granted
permission for implementation on May 11, 2015. The organization where the EBP
protocol was conducted did not require IRB approval.
Participation recruitment commenced on May 13, 2015 and was scheduled to
terminate on July 31, 2015 (10 weeks) according to IRB approval. The investigator
projected to enroll 15-20 participants. A modification due to unforeseen circumstances
prevented participation enrollment for 3 days. Participants were identified through the
Medent electronic medical record of patients who have been seen within the past 6
months for symptoms related to IC as well as any new patients with symptoms related to
IC. Established patients were contacted by either the investigator or the office manager to
assess symptom management. If the patient did not feel as though their symptoms were
being controlled, they were asked if they would like to come into the office for follow up
evaluation. Through the evaluation process, some participants did not wish to proceed
with pelvic floor therapy due to time or travel constraints and were not included in the
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study.
If the patient was established, a physical examination was performed and the
O’Leary-Sant problem and symptom index questionnaire was completed. Eligible
participants received a project consent form to participate in the EBP change intervention
by the investigator. The investigator reviewed the consent form and participants were
allowed the opportunity to ask the investigator any questions related to the consent
process and EBP change project prior to agreeing to participate. Agreement to participate
was established by signing the consent, however the participants were made aware that
they may withdraw at any time without any repercussion.
New patients presenting with symptoms of IC received a complete history and
physical examination voiding diary, post void residual, full gynecological examination,
urinalysis with culture, urine cytology if the patient had a smoking history, and pain
evaluation. Further evaluation to eliminate other conditions such as irritable bowel
syndrome, fibromyalgia, vulvodynia, endometriosis, or vaginal infections were addressed
prior to review of project and consent. After consent was signed, the patient was then
educated on self-care practices and behavior modification such as diet modifications to
include the elimination of caffeine, alcohol, acidic or spicy foods, bladder retraining,
gentle, non-jarring exercise/stretching, wearing comfortable, non-binding clothing, shoes,
hosiery and underwear as well as stress management and coping techniques to include
relaxation techniques, and emotional support was given. The patient was then educated
on pelvic floor therapy and a brochure from the Interstitial Cystitis Association was given
along with information regarding bladder irritants and bladder training. Pelvic floor
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therapy was ordered and the patient was scheduled for a 4-week follow up with
instructions to call with any concerns in the meantime. One hour of appointment time
was allotted for each patient. The patient understood that due to unforeseen
circumstances, the conclusion of IRB approval was indicated as July 31, 2015 and the full
12 weeks would not be assessed for this EBP project, however the patient would still be
followed the same as discussed according to the consent with follow up at 4 weeks, 8
weeks, and 12 weeks with final project evaluation at 8 weeks. The investigator received
updates from the pelvic floor therapist throughout treatment. At the 4-week follow up
visit, the O’Leary-Sant problem and symptom questionnaire was completed to determine
continuity of care.
Information in regards to the patients pre-test O’Leary-Sant questionnaire scores
and post-test scores were extrapolated and analyzed. The EBP intervention’s next steps
include dissemination of the findings. A power point presentation was created to
overview the clinical problem, intervention and findings. The oral defense presentation
was scheduled for August 14, 2015 with the final DNP project paper submission on
August 16, 2015 for review by faculty. Recommendations for continued surveillance and
implementation were discussed as well as opportunities to present findings at local and
national conferences will be explored.
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Chapter Six: Evaluation and Outcomes
	
  

Interstitial cystitis/painful bladder syndrome is a problem that has the potential to
affect a woman in many aspects of her life to include social, emotional and economical
areas. Pelvic floor therapy, when performed properly with collaboration of care with the
patient’s urologist/gynecologist, has been shown to be a more effective treatment for
IC/PBS (FitzGerald, et al. 2012). This evidence-based practice (EBP) project sought to
determine if PFT in conjunction with usual care would be an effective intervention
among women in a Urology/Gynecology practice located within the northeastern United
States.
Mean was used to characterize the participant population. Nine women
volunteered to participate in the EBP change project. The participants in this evidencebased practice change project were females ranging in age from 26 to 82 years old, with a
mean age of 51 years. No women under twenty-six years opted to participate in the
project. Each participant suffered from IC/PBS symptoms. Only 9 of the expected 15
women were enrolled due to time constraints. However the study was still able to
adequately identify significant differences in the primary outcome of the study. The
average length of diagnosis ranged from newly diagnosed to 10 years, with a mean of 3
years.
The O’Leary-Sant voiding and pain indices measurement tool determining
symptom index and problem index was to be utilized in a pre-test, 4 weeks, 8 weeks and
post-test format to assess the effectiveness of the intervention of PFT among a group of
participants over the age of 18 years. However, due to time constraints this utilization
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tool was used as a pre-test, 4 week and 8 week format (Tables 1 and 2).
The Interstitial cystitis symptom index contains 4 items that measure symptoms
demonstrated over the last month that consist of the strong need to urinate with little or
no warning, the feeling of having to urinate 2 hours after finishing, number of nighttime
urination, and pain or burning in the bladder. The ICSI index score is the sum of the item
scores (range: 0-21).
Table 1
O’Leary-Sant Symptom Index Scores
IC Symptom Index

Before Treatment

4 Weeks

8 Weeks

Patient #1

14

11

7

Patient #2

18

7

3

Patient #3

15

9

4

Patient #4

14

10

6

Patient #5

11

7

3

Patient #6

14

9

5

Patient #7

10

9

6

Patient #8

16

11

4

Patient #9

15

12

8

The Interstitial cystitis problem index contains 4 items that measure how much of a
problem the following had over the past month: frequent urinating during the day,
nighttime urination, the need to urinate with little warning, and burning, pain, discomfort,
or pressure of the bladder. The ICPI score is the sum of the item scores (range: 0-16).
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Table 2
O’Leary-Sant Problem Index Scores
IC Problem Index

Before Treatment

4 Weeks

8 Weeks

Patient #1

15

11

7

Patient #2

14

5

4

Patient #3

10

5

2

Patient #4

13

8

5

Patient #5

11

8

2

Patient #6

12

9

4

Patient #7

13

12

7

Patient #8

12

10

6

Patient #9

13

12

6

Data Analysis and Results
Pelvic Floor Therapy consisted of therapeutic exercises, manual therapy,
neuromuscular reeducation, pain management, patient education and posture/body
mechanics. Usual care consisted of education on self-care practices and behavior
modification such as diet modifications to include the elimination of caffeine, alcohol,
acidic or spicy foods, bladder retraining, gentle, non-jarring exercise/stretching, wearing
comfortable, non-binding clothing, shoes, hosiery and underwear as well as stress
management and coping techniques to include relaxation techniques. An average of 62%
decrease in the O’Leary-Sant symptom index was reported over an 8-week period of
pelvic floor therapy consisting of a 1-hour sessions once or twice a week dependent on
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duration and severity of symptoms. An average of 63% decrease in the O’Leary-Sant
problem index was reported over the same breadth of time. All patients met the criteria of
completing the trial. The therapy was well accepted and well tolerated, and follow up was
considered good. A paired t test was calculated which showed a symptom index p-value
of 0.0010. The 95% confidence interval ranged from 2.53 to 6.81 as the mean of the pre
test minus the post-test was equal to 4.67 (Table 3). The paired t test was also calculated
for the problem index, which showed a p-value of 0.0001. The 95% confidence interval
ranged from 6.78 to 8.78 as the mean of the pre test minus the post-test was equal to 7.78.
Therefore the response rate was considered highly statistically significant (Table 4).
Table 3
O’Leary-Sant Symptom Index Statistics
IC Symptom Index

Pre Treatment Post Treatment

Mean

14.11

9.44

Standard Deviation

2.42

1.74

Standard Error of Mean

0.81

0.58

Number

9

9
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Table 4
O’Leary-Sant Problem Index Statistics
IC Problem Index

Pre Treatment Post Treatment

Mean

12.56

4.78

Standard Deviation

1.51

1.92

Standard Error of Mean

0.50

0.64

Number

9

9

Relationship of Results to Framework and Objectives
IC/PBS is frequently associated with pelvic floor dysfunction. For this group of
patients, it is obligatory to observe not only the bladder, but also all the other organs
inside the pelvis. An optimal approach is a combined treatment oriented not only to treat
the bladder, but also to include the other components responsible for this pain disorder.
This evidence based change project has shown that pelvic floor therapy as part of usual
care is helpful in managing pelvic pain and relaxing the pelvic floor. Treatment should
continue until tenderness and tightness are minimized or resolved, which requires one or
two visits per week for 8 to 12 weeks depending on the duration and severity of
symptoms. As symptoms decrease in severity, frequency of therapy is decreased and the
patient continues with home pelvic muscle stretches and relaxation techniques (Peters &
Carrico, 2006).
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Population: In women 18 years and older with interstitial cystitis/painful bladder
syndrome.
The participants in this evidence based practice change project included females
ranging in age from 26-82 years with a mean age of 51 years. N = 9 out of 11 as 2
patients declined to participate as they reported fear of pain with pelvic floor therapy or
too far of a distance to travel. Two of the patients were established IC patients who had
never received pelvic floor therapy with seven newly diagnosed patients.
Intervention: Pelvic floor therapy as part of usual care.
Pelvic floor therapy was ordered as evaluation and treatment of up to 12 weeks.
The pelvic floor therapist provided evaluation updates throughout treatment. The two
established patients indicated continued usual care. The seven new patients were
educated on usual care as well as pelvic floor therapy. No pharmacological therapies
were administered throughout this EBP change project.
Outcome/Time Improve symptoms as indicated by reduction in the patients O’Leary-Sant
Interstitial Cystitis Symptom Index (ICSI) score over and 8 week period.
Results indicate that (n = 9), there was a significant (p <0.0010) improvement
from baseline in the patients’ O’Leary-Sant IC symptom index as well as (n = 9), there
was a significant (p < 0.0001) improvement from baseline in the patients’ O’Leary-Sant
IC problem index over the 8 week time period.
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Chapter Seven: Implications for Nursing Practice
	
  

Planning and implementing evidence-based practice (EBP) changes and quality
improvement is the future of the profession of nursing begins with formative education
and continues throughout the nurses’ career. EBP implications should be explicitly
valued by the nursing profession at all levels increasing healthcare environments needed
to support EBP activities as part of career development. This chapter will discuss the
clinical implications of this practice change project. It will focus on implications for
nursing practice, review the strengths and limitations of this project and discuss its
linkage to DNP Essentials.
In January 2011, the American Urological Association (AUA) recommended
starting treatment of IC/PBS with the most conservative treatments to include stress
management, patient education and self-care (Theoharides, & Whitmore, 2011).
However, according to Cervigni and Natale, (2014), many patients with IC /PBS have
concomitant pelvic floor hypertonicity estimating the prevalence ranging form 50% to
87% noting that pelvic floor dysfunction exacerbates IC/PBS symptoms. Therefore,
pelvic floor therapy should be considered as a first line treatment in these cases.
Although the concept of applying “best evidence” in a clinical decision seems
forthright, it is actually very complex. Skillful critical thinking is required to evaluate the
evidence for its strength and scientific rigor. Moreover, it needs to be well thought out in
light of the patient’s concerns and preferences (Melnyk & Finehout-Overholt, 2005). The
impact from this EBP change project is influential. The results are an important aspect of
bringing recognition to the complex roles of APNs and their impact on outcomes. The
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findings demonstrated that providing best practice resources could lead to rapid
interventions for women with IC/PBS. The collaborative work with trained pelvic floor
therapists will influence the ability to integrate additional EBP changes.
Strengths of the Project
The quality of data is considered high. According to Burns and Grove (2003),
quality data are best obtained from articulate, well-informed participants who are able to
share more rich data in a clear and concise manner. The participants in this EBP change
project were allotted more than the usual 15-minute time period to be interviewed at
greater depth and breadth.
Reliability testing measures the amount of random error in the measurement
technique, taking into account dependability, consistency, accuracy, and comparability.
The same pelvic floor therapist measured patient outcomes through the same biofeedback
and reported to the investigator throughout care of each patient, therefore reliability is
considered to be high.
The O’Leary-Sant Questionnaire used to assess symptom and problem index is
considered valid. This instrument has been used by the American Urological Association
(2013) to establish guidelines related to IC/PBS, and the RAND Interstitial Cystitis
Epidemiology study (Konkle et al., 2012). This instrument measures all major elements
relevant to the concept being measured.
Limitations of the Project
There were some limitations to this EBP change project. Current research lacked
studies on the effectiveness of a multimodal approach to treatment of IC/PBS. A few
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studies showed benefits to stress reduction, behavior modification, improved coping
mechanisms, and diet modifications as first line treatment. Another limitation that was
identified early in the project was the probability of a limited number of participants,
although it was felt by the author that enough data was collected to show the projected
outcomes were met. Limited participants were obtained due to time constraints related to
delayed IRB approval and completion dates as well as two patients who refused to
participate. Since the number of participants in this project was small, the results cannot
be predicted to what may occur in a larger population setting. And, the outcomes data
from the participants was based on self-report in a pre and posttest format therefore
results may have been more biased than what this investigator would have preferred.
Linkage to DNP Essentials
The mandate for evaluation is integral to professional nursing practice. The DNP
Essentials serve as a blueprint for the education of Advanced Practice Nurses at their
respective levels of competencies (Hickey & Brosnan, 2012). Recommendations that
nurses practicing at the highest level should receive doctoral level preparation acquiring
knowledge required for safe nursing practice and growing concerns regarding the quality
of patient care delivery and their outcomes (American Association of College of Nursing,
2006).
Essential I: The DNP prepared nurse integrates nursing science with knowledge
from ethics, the biophysical, psychosocial, analytical, and organizational sciences as the
basis for the highest level of educational preparation in nursing (AACN, 2006). Sciencebased theories and concepts are used to determine the significance of health and the
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healthcare delivery phenomena, describe actions and strategies to enhance, alleviate, and
improve health care delivery as appropriate and develop new approaches based on theory
(AACN, 2006).
Analytical reasoning provided the framework for scientific knowledge of the
IC/PBS practice change project. This project focuses on symptom and problem index
related to experience, management strategies and outcomes, which is applicable to
advanced nursing practice and research in addition to providing direction for selecting the
delivery of clinical interventions for successful outcomes.
Essential II: Organizational and Systems Leadership for Quality
Improvement and Systems Thinking. Organizational and system leadership are critical
for improving patient and health care outcomes (AACN, 2006). Development and
evaluation of care delivery approaches that meet the needs of health disparities, patient
safety, and excellence in practice comprises this essential. Ensuring accountability to
clinical policy, process improvement and facilitation in organization-wide changes in
health care describe components of the DNP prepared nurse. A major goal of the IC/PBS
practice change project was to provide evidenced-based care and to decrease this disease
disparity while upholding patient safety.
Essential III: Clinical Scholarship and Analytical Methods for Evidence-Based
Practice. The vigorous nature of health care requires that the DNP prepared nurse be
current on new information while disseminating findings into clinical practice. Using
analytical methods to critically appraise existing literature and other evidence pertinent to
practice, the DNP prepared nurse employs evidence-based practice to improve patient
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and population outcomes. An extensive review of the literature was conducted to identify
the best evidence-based practice application to achieve symptom and problem
management of IC/PBS.
Essential IV: Information Systems/Technology and Patient Care Technology
for the Improvement and Transformation of Health Care. DNP prepared nurses are
characterized by their abilities to use information systems and technology to support and
improve patient care and healthcare systems as well as provide leadership within
healthcare systems and/or academic settings (AACN, 2006). The IC/PBS change project
required technological data extraction from the O’Leary-Sant voiding and pain indices
questionnaire to measure outcomes. A Power Point presentation was developed for
doctoral defense as well as presentation at local and national conferences.
Essential V: Health Care Policy for Advocacy in Health Care. Health care policy
creates a framework that can facilitate or obstruct the delivery of health care services or
the ability of the provider to engage in practice to address health care needs. DNP
graduates are equipped to design, influence, and implement health care policies that
frame health care by proactively developing and implementing policy at all levels,
including institutional, local, state, regional, federal and international (AACN, 2006). The
IC/PBS change project influences future implications to improve IC/PBS guidelines for
first line therapy.
Essential VI: Interprofessional Collaboration for Improving Patient and
Population Health Outcomes. DNP prepared nurses employ effective team leadership and
are prepared to play a central role in established collaborative teams, participating in the
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work of the team and assuming leadership of the team when appropriate (AACN, 2006).
The collaboration between pelvic floor therapy specialists, nurse scholars, peers, and
other health care professionals allowed for effective communication in the development
and implementation of this practice model.
Essential VII: Clinical Prevention and Population Health for Improving the
Nation’s Health. Implementation of clinical prevention and population health activities is
essential to achieving the national goal of improving the health status of the population of
the United States (AACN, 2006). Consistent with the national calls for action, DNPs
must serve as leaders in affirming quality care to achieve greater levels of excellence.
Current concepts of public health such as health promotion, evidence-based practice
recommendations, determinants of health, environmental and occupational health, and
cultural diversity and sensitivity guide the practice of DNP graduates (AACN, 2006).
IC/PBS imposes an increasing burden in the United States in terms of quality of
life, and healthcare costs (Payne, Joyce, Wise &Clemens, 2007). This EBP change
project emphasizes the collaborative roles of the health care team and the patients
demonstrating positive outcomes, which are essential to influence population health.
Essential VIII: Advanced Nursing Practice. The foundational practice
competencies that connect specialties are seen as obligatory for the DNP prepared nurse
practice, which is specified in Essential VIII. DNP prepared nurses are projected to
demonstrate refined assessment skills and base practice with the application of
biophysical, psychosocial, behavioral, sociopolitical, cultural, economic, and nursing
sciences as appropriate in their area of specialization (ACCN, 2006). The IC/PBS project
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is an example of implementing evidence-based practice built on the premise of national
and international findings to advance nursing practice.
Conclusion
Activities that analytically advance the teaching, research, and practice of nursing
through rigorous inquiry are significant to the nursing profession (AACN, 2006). DNP
prepared nurses project quality and safety interventions that are evidence based and
population appropriate to reduce underlying causes and promote appropriate treatment of
chronic diseases (Cupp Curley & Vitale, 2012). Employing the AACN Essentials for this
evidence-based practice change project allowed the investigator to identify specific
competencies that were demonstrated to advance nursing practice.
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Chapter Eight: Summary of Project and Conclusions
	
  

Evidence-based practice is an approach that enables health care providers to deliver
the highest quality of care in meeting the multifaceted needs of patients and families.
When healthcare providers know how to find, critically appraise, and practice the best
evidence, and when patients are confident that their healthcare providers are using
evidence-based care, ideal outcomes are achieved for all (Melnyk & Fineout-Overholt,
2005). The literature indicates that approximately 2.7% to 6.5% of American women age
18 years and over met symptom criteria for IC/PBS. When extra-populated to the general
population, these numbers translate to between 3.4 and 7.9 million women who have
symptoms consistent with this debilitating condition (Kerr, 2009).
Change in Clinical Practice
An extensive search of current literature was first conducted to answer the PICO-T
question; “In women 18 years and older with interstitial cystitis/painful bladder
syndrome, does pelvic floor therapy as usual care improve symptoms indicated by
reduction in the patients O’Leary-Sant Interstitial Cystitis Symptom Index (ICSI) score
over an 8 week period”. The evidence had shown that addressing the pelvic floor in
patients demonstrating IC/PBS symptoms had great importance. Current literature
supports statistically significant correlations between usual care and pelvic floor therapy
related to both cost benefits and quality of life to the patient. Utilizing the findings in
practice and implementing coordination of care between a practitioner and professionally
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trained physical therapist would prove to be beneficial in the treatment of IC/PBS.
The health issue addressed in this EBP change project was the effectiveness of
implementing standard of best care practices including pelvic floor therapy in the
management of women years 18 and older with interstitial cystitis/painful bladder
syndrome. This project provided the investigator an empirical learning opportunity to
develop the knowledge and skills necessary to provide patient-centered care, work with
an interdisciplinary team, utilize informatics, and apply research findings in practice.
The support of the clinical practice setting and their commitment to excellence
made the project very adaptable. The Rosswurm and Larrabee Model served as the guide
to integrate research into daily practice. Members of the interdisciplinary team devoted
considerable efforts to facilitate the implementation of this evidence-based practice
change project. Without this level of support, success would have been hard to achieve.
(Gawlinski & Rutledge, 2008).
After obtaining support from the Advanced Gynecology Practice site, an
application to the Misericordia University IRB board was submitted and approval for this
EBP change project was obtained on May 11, 2015. Several office meetings were then
held with the clinical office staff to review the EBP change project as well as include
logistics in approaching potential participants. The investigator obtained and developed
documents such as consent form, O’Leary-Sant Questionnaire, bladder irritants, timed
voids and brochures provided by the ICA association in regards to stress reduction, self
help and pelvic floor therapy.
The investigator approached 11 potential participants with 9 females age 26-82
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years who consented to participate. There were several reasons that potential participants
chose not to participate. These included time constraints, travel distance to physical
therapy and fear of therapy due to pain. The desired outcome of this project was a
decrease in the O’Leary-Sant symptom and problem index scores reported by a pre test, 4
week and post test. The results indicated that all participants reported an improvement in
symptom and quality of life following the intervention. The analysis of pre test and post
test data showed that an average of 62% decrease in the O’Leary-Sant symptom index
and a 63% decrease in the O’Leary-Sant problem index was reported over the 8 week
time period with a statistically significant symptom index p-value of 0.0010 and problem
index p value of 0.0001.
Conclusion
The EBP change project of implementing standard of best care practices including
pelvic floor therapy as usual care in the management of women years 18 and older with
interstitial cystitis/painful bladder syndrome was shown to be effective for symptom and
quality of life improvement. Many of the equivalent findings that were present in the
literature review were also revealed in the project. The age ranges of the majority of
IC/PBS sufferers were similar. Despite the small sample size, the EBP project was
successful and met the standards of improvement in symptoms and quality of life from
this disease. Analysis of the pre-test and post-test measurement tool scores showed that
the project was statistically significant for improvement of IC/PBS symptoms.
The EBP project flowed well and the intervention of practice to include pelvic
floor therapy as first line treatment for IC/PBS will be implemented in the
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Urology/Gynecology practice on a regular basis. An EBP project such as this has the
ability to significantly impact women who suffer from this condition by allowing them to
improve their health-related quality of life.
Dissemination Plans
The doctor of nursing practice (DNP) degree has created opportunities for nurses
to implement their EBP projects in collaboration with academic and clinical teams.
Findings from such innovative efforts have unique dissemination presentation venues.
Approaches for dissemination of such projects include most importantly, the oral defense
presentation followed by power point or poster presentations at local or national
conferences, journal clubs and seminars as well as disseminating evidence through
publication (Melnyk & Finout-Overholt, 2005).
Future Implications for Practice
Applying the EBP change project to all patients presenting with this disease will
determine the significance of health and delivery of healthcare to alleviate symptoms
related to IC/PBS while continuing to evaluate care delivery approaches that meet the
needs of health disparities, patients safety and excellence in practice. Continued
collaboration with pelvic floor therapists, peers, nurse scholars and other healthcare
professionals to critically appraise existing literature and other evidence pertinent to
practice will improve patient and population outcomes and advocate for healthcare policy
change in IC/PBS guidelines for first line therapy (AACN, 2006).
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